ArticleiScience2026
A unique malignant cell type per patient tumor encoded in each cancer cell transcriptome.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deciphering shared features between patients through unsupervised analyses of tumor single-cell transcriptomes is hindered by the predominant clustering of malignant cells based on the patients' tumor of origin. In contrast, cancer-associated non-malignant cell cluster according to their cell type (e.g., macrophage), independently of the patient. We investigated the origin of this contrasting clustering behavior using computational analyses and data sampling techniques across 14 cancer types. We demonstrate that tumor-driven malignant cell clustering is independent of technical or computational biases and non-reducible to tumor-specific gene sets. Conversely, redundant information dispersed across the transcriptome encodes a unique identity shared by malignant cells within each patient's tumor. Identity of normal cell types is similarly encoded. Finally, we demonstrate maintenance of malignant cell identity across space and over time. These findings suggest the establishment of a distinct type of malignant cells within each patient's tumor, robustly and diffusively encoded across the entire transcribed genome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.